MAPK8 and cancer: In addition, Sestrin2 overexpression inhibits cancer growth by the activation of various signaling pathways such as MAPK4/SAPK/JNK1/Jun kinase, MAPK8/Jun, and the inhibition of x-linked inhibitor protein (XIAP) 145.